| All news about OYSTER POINT PHARMA, INC. |
|
|
|
|
|
|
|
| 2022 sales |
33.0 million
–
–
|
| 2022 net income |
-168M
–
–
|
| Net cash 2022 |
49.0M
–
–
|
| PER 2022 ratio |
-0.76x |
| 2022 return |
– |
|
| Capitalization |
125 million
125 million
–
|
| EV / Sales 2022 |
2.29x |
| EV / Sales 2023 |
1.28x |
| # of employees |
303 |
| Floating |
94.6% |
|
| Chart OYSTER POINT PHARMA, INC. |
|
Duration :
Period :
|
 |
|
|
Trends in Technical Analysis OYSTER POINT PHARMA, INC.
|
Short term |
Middle term |
Long term |
| Tendencies |
Bullish |
Bearish |
Bearish |
Evolution of the income statement
|
|
| Medium consensus |
TO BUY |
| Number of analysts |
4 |
| Last closing price |
$4.67 |
| Average target price |
$32.75 |
| Average Spread / Target |
601% |
|
